Literature DB >> 10094394

Murine protein kinase CK2: gene and oncogene.

X Xu1, E Landesman-Bollag, P L Channavajhala, D C Seldin.   

Abstract

Protein kinase CK2 (casein kinase II) is a serine-threonine protein kinase with a wide range of substrates, many of which are involved in cell cycle regulation. CK2 activity is elevated in a variety of human tumors and we have used a transgenic mouse model to demonstrate that dysregulated expression of CK2 can induce lymphoma. Thus, CK2 fulfills the definition of an oncogene: A mutated, dysregulated, or mis-expressed gene that contributes to cancer in a dominant fashion. CK2 cooperates in transforming cells with other lymphoid oncogenes such as myc and tal-1, and here we show cooperativity with loss of the tumor suppressor gene p53. To understand more about the physiological and pathological role of CK2, we are cloning the murine CK2alpha' cDNA and gene. CK2alpha' will be used to generate transgenic and knockout mice and the regulatory elements for gene expression will be analyzed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094394

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  51 in total

Review 1.  Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes.

Authors:  L Weis; D Reinberg
Journal:  FASEB J       Date:  1992-11       Impact factor: 5.191

Review 2.  Casein kinase 2: an 'eminence grise' in cellular regulation?

Authors:  L A Pinna
Journal:  Biochim Biophys Acta       Date:  1990-09-24

3.  Casein kinase II. cDNA sequences, developmental expression, and tissue distribution of mRNAs for alpha, alpha', and beta subunits of the chicken enzyme.

Authors:  G Maridor; W Park; W Krek; E A Nigg
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

4.  Casein kinase II from Caenorhabditis elegans. Properties and developmental regulation of the enzyme; cloning and sequence analyses of cDNA and the gene for the catalytic subunit.

Authors:  E Hu; C S Rubin
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.

Authors:  M A Kelliher; D C Seldin; P Leder
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.

Authors:  K Appel; P Wagner; B Boldyreff; O G Issinger; M Montenarh
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

7.  p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.

Authors:  G Bakalkin; G Selivanova; T Yakovleva; E Kiseleva; E Kashuba; K P Magnusson; L Szekely; G Klein; L Terenius; K G Wiman
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

8.  Cardiac myotrophin exhibits rel/NF-kappa B interacting activity in vitro.

Authors:  N Sivasubramanian; G Adhikary; P C Sil; S Sen
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

9.  Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle.

Authors:  D C Seldin; P Leder
Journal:  Science       Date:  1995-02-10       Impact factor: 47.728

10.  p53-catalyzed annealing of complementary single-stranded nucleic acids.

Authors:  P Oberosler; P Hloch; U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  19 in total

1.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

3.  Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization.

Authors:  Alexander V Ljubimov; Sergio Caballero; Annette M Aoki; Lorenzo A Pinna; Maria B Grant; Raquel Castellon
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

4.  CK2 binds, phosphorylates, and regulates its pivotal substrate Cdc37, an Hsp90-cochaperone.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

Review 5.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

6.  Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation.

Authors:  Alexander Plotnikov; Dana Chuderland; Yael Karamansha; Oded Livnah; Rony Seger
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

7.  Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.

Authors:  Cinzia Franchin; Christian Borgo; Luca Cesaro; Silvia Zaramella; Jordi Vilardell; Mauro Salvi; Giorgio Arrigoni; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2017-11-09       Impact factor: 9.261

8.  Phosphorylated human keratinocyte ornithine decarboxylase is preferentially associated with insoluble cellular proteins.

Authors:  M M Pomidor; R Cimildoro; B Lazatin; P Zheng; J A Gurr; I M Leigh; O A Jänne; R S Tuan; N J Hickok
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

9.  Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biochem       Date:  2008-06-20       Impact factor: 3.396

10.  Identification and characterization of a novel testis-specific gene CKT2, which encodes a substrate for protein kinase CK2.

Authors:  Xiyuan Bai; Derek Silvius; Edward D Chan; Denise Escalier; Shaun Xin Xu
Journal:  Nucleic Acids Res       Date:  2009-03-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.